νλΌλνλ‘μ¬μ
**νλΌλνλ‘μ¬μ (Pradofloxacin)**μ 3μΈλ κ΄λ²μ μμμ© ν루μ€λ‘ν΄λλ‘ κ³ νμμ μ λλ€. λ€μν κ·Έλ μμ±κ· λ° κ·Έλ μμ±κ· μ λν΄ λλ μμ‘΄μ μ΄κ· νμ±μ λνλ΄λ©°, μ΄κΈ° ν루μ€λ‘ν΄λλ‘ κ³μ λΉν΄ νκΈ°μ± μΈκ· μ λν νμ±μ΄ ν¬κ² ν₯μλμμ΅λλ€. > **μμ κ²½κ³ :** ν루μ€λ‘ν΄λλ‘ κ³ μ½λ¬Όμ λ°°μ λ° κ°μμ± κ²μ¬μμ μμμ λ°μμ΄ μμΈ‘λκ³ 1μ°¨ λ° 2μ°¨ νκ· μ κ° ν¨κ³Όκ° μμ κ²μΌλ‘ μμλλ κ°μΌμλ§ μ νμ μΌλ‘ μ¬μ©ν΄μΌ ν©λλ€. **μμ ν:** νλΌλνλ‘μ¬μ μ μ§μ©μ±μ΄ λ§€μ° λ°μ΄λ λΉλ¨μμκΈ° λ° μ 립μ μ ν¬ν¨ν μ‘°μ§μ λμ λλλ‘ λλ¬ν©λλ€. νΉμ μ μμ¦μΌλ‘λ νμ¬μ± λ° μ¬μ¬μ± λνΌμ¦, μμ² κ°μΌ(μλμΈν°λ―Έλμ°μ€ ν¬λμκ΅¬κ· ), μλ‘ κ°μΌ(λμ₯κ· , μλμΈν°λ―Έλμ°μ€ ν¬λμκ΅¬κ· ), μ€μ¦ μΉμ£Ό μ§ν(ν¬λ₯΄νΌλ‘λͺ¨λμ€ μ’ , ν리보ν λΌ μ’ ) λ° κΈμ± μ€μ¦ μκΈ°λ κ°μΌμ΄ μμ΅λλ€.
μμ© κΈ°μ : Pradofloxacin is a concentration-dependent bactericidal antibiotic. It works by entering the bacterial cell and inhibiting two key enzymes: **DNA gyrase** (topoisomerase II) and **topoisomerase IV**. Inhibition of these enzymes β prevents DNA supercoiling and uncoiling β blocks bacterial DNA replication, transcription, and repair β rapid bacterial cell death.
λλ¬Ό μ’ λ³ μ©λ
- Susceptible bacterial infections Β· 3-5 mg/kg Β· PO Β· q24h Β· As directed by clinician based on infection type Β· See guidelines on responsible antibacterial use
- Susceptible bacterial infections Β· 3-5 mg/kg Β· PO Β· q24h Β· As directed by clinician based on infection type Β· Tablet formulation
- Susceptible bacterial infections Β· 5.0 mg/kg Β· PO Β· q24h Β· As directed by clinician based on infection type Β· Suspension formulation
μ©λμ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μ°Έκ³ μλ£μ λλ€. νμ μ΅μ λΌλ²¨κ³Ό κ°λ³ νμμ λν΄ νμΈνμμμ€.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Pregnant or lactating animals
- Dogs < 12 months of age (< 18 months for giant breeds)
- Cats < 6 weeks of age
- Animals with persistent cartilage lesions
- Dogs or cats with neurological disease (especially epilepsy)
μ΄μλ°μ
- Mild gastrointestinal upset (vomiting, diarrhea, anorexia)
μ½λ¬Ό μνΈμμ©
- Antacids (Mg2+, Al3+) Β· Binds fluoroquinolones, preventing absorption from the GI tract Β· major
- Sucralfate Β· Inhibits absorption; separate dosing by at least 2 hours Β· major
- Zinc salts Β· Inhibits absorption; separate dosing by at least 2 hours Β· moderate
- Theophylline Β· Increases plasma theophylline concentrations Β· major
- Cimetidine Β· May reduce the clearance of fluoroquinolones Β· moderate
- Ciclosporin Β· May decrease metabolism and increase nephrotoxicity; concurrent use best avoided Β· major
- Tacrolimus Β· May decrease metabolism and increase nephrotoxicity; concurrent use best avoided Β· major
- Oral anticoagulants Β· May increase the action of orally administered anticoagulants Β· moderate
λͺ¨λν°λ§
- Clinical efficacy (resolution of infection)
- Gastrointestinal signs
- Neurological status (especially in predisposed animals)
κ³Όμ©λ
Overdose may increase the risk of gastrointestinal upset, neurological signs (tremors, seizures), and cartilage damage in growing animals. Treatment is symptomatic and supportive. Emptying the stomach and administering activated charcoal may be beneficial if ingestion was recent.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.